Ironwood Pharmaceuticals
IRWD
IRWD
193 hedge funds and large institutions have $1.8B invested in Ironwood Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 69
1% less funds holding
Funds holding: 195 → 193 (-2)
24% less capital invested
Capital invested by funds: $2.36B → $1.8B (-$560M)
Holders
193
Holding in Top 10
3
Calls
$6.98M
Puts
$1.02M
Top Buyers
| 1 | +$32.5M | |
| 2 | +$23.7M | |
| 3 | +$18.3M | |
| 4 |
BM
Bridger Management
New York
|
+$15.6M |
| 5 |
SPC
Slate Path Capital
New York
|
+$13.5M |
Top Sellers
| 1 | -$31M | |
| 2 | -$12.4M | |
| 3 | -$10.8M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$9.24M |